TVAX Biomedical ipo stock symbol

TVAX Biomedical ipo stock symbol : TVAX Biomedical, a biotech company focused on cancer cell vaccination and T cell cancer treatment, announced terms for its IPO on Monday. The Lenexa, KS-based company plans to raise $20 million by offering 2 million shares at a price range of $9.00 to $11.00.

At the mid-point of the proposed range, TVAX Biomedical will command a market value of $81 million. TVAX Biomedical, which was founded in 2004, plans to list on the NASDAQ under the symbol TVAX. Roth Capital is the lead underwriter on the deal. For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post: